Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
LakePharma has announced the launch of GMP manufacturing of recombinant proteins and antibodies with CHO-GSN™ and TunaCHO™ platforms at its Hayward, California facility.
read more
Lannett has entered into separate agreements with three strategic alliance partners.
read more
Monday, December 23, 2019
Lannett has received approvals from the FDA of its ANDAs for Butalbital, Acetaminophen and Caffeine Capsules.
read more
Wednesday, November 01, 2017
Lannett has entered into a settlement and license agreement with Celgene Corporation that resolves patent infringement litigation in the U.S. related to Celgene's Thalomid.
read more
Lantern Pharma announced agreements with contract manufacturing companies for process development and manufacturing for two of Lantern's oncology drug candidates, LP-300 and LP-184.
read more
Wednesday, February 13, 2013
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of a Supplemental New Drug ...
read more
LaunchWorks Manufacturing Lab, a company serving the life science market, is now LaunchWorks CDMO.
read more
LaunchWorks CDMO has been approved to manufacture and distribute Viral Transport Media, in accordance with Section IV.B of the FDA’s COVID-19 Transport Media Policy.
read more
Tuesday, February 03, 2015
Dr. Satyanarayana Chava, Founder and CEO of Laurus Labs Private Limited, India, today announced that the company has launched Laurus Synthesis Inc., a new U.S. pharmaceutical and biotech services entity. Laurus Synthesis Inc. will operate under the ...
read more
Leidos was recently awarded a new prime contract to provide biomedical preclinical and development capabilities to support the National Institute of Allergy and Infectious Diseases (NIAID).
read more
Thursday, December 02, 2021
Leucid Bio a biotech company pioneering next-generation cell therapies for hard-to-treat cancers, today announces that it has entered a strategic collaboration with Lonza to utilize Lonza's Cocoon® Platform for the Company's forthcoming Phase I ...
read more
LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma.
read more
Life Technologies Corporation today announces plans to invest $18 million in a multi-phase plan to expand its facility in Pleasanton, Calif., where it will implement Current Good Manufacturing Practice (cGMP) capabilities for its genetic analysis ...
read more
Eli Lilly and Company has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic medicines, as well as a manufacturing facility in Suzhou, China to Eddingpharm.
read more
Wednesday, March 04, 2020
Among the concerns raised due to the impact of the novel coronavirus is whether patients can count on a reliable supply of medicine.
read more